Overall, these studies propose that epimorphin activates αV integrin receptors and the transcription factors C/EBPβ and KLF4 which can be a positive regulator of endogenous epithelial differentiation in ovarian cancer cells. Here, CEBPB is linked to ovarian carcinoma.